Orserdu Interactions
There are 223 drugs known to interact with Orserdu (elacestrant), along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 79 are major, 143 are moderate, and 1 is minor.
- View all 223 medications that may interact with Orserdu
- View Orserdu alcohol/food interactions (1)
- View Orserdu disease interactions (1)
Most frequently checked interactions
View interaction reports for Orserdu (elacestrant) and the medicines listed below.
- albuterol
- Ambien (zolpidem)
- aspirin
- atenolol
- atorvastatin
- biotin
- Breztri Aerosphere (budesonide / formoterol / glycopyrrolate)
- Calcium 600 D (calcium / vitamin d)
- calcium carbonate
- calcium citrate
- carvedilol
- Centrum Silver Women's (multivitamin with minerals)
- Claritin (loratadine)
- clopidogrel
- Compazine (prochlorperazine)
- Cymbalta (duloxetine)
- diltiazem
- doxepin
- famotidine
- fulvestrant
- gabapentin
- Gaviscon Extra Relief Formula (alginic acid / aluminum hydroxide / magnesium carbonate)
- Ibrance (palbociclib)
- ibuprofen
- omeprazole
- oxybutynin
- Verzenio (abemaciclib)
- Vitamin D3 (cholecalciferol)
- warfarin
- Xgeva (denosumab)
Orserdu alcohol/food interactions
There is 1 alcohol/food interaction with Orserdu (elacestrant).
Orserdu disease interactions
There is 1 disease interaction with Orserdu (elacestrant) which include:
More about Orserdu (elacestrant)
- Orserdu consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: estrogen receptor antagonists
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.